May 19, 2020 / 11:56 AM / 7 days ago

Phlow gets $354 million U.S. funding to ensure drug supply amid COVID-19 pandemic

(Reuters) - U.S. drug manufacturer Phlow said on Tuesday it had received $354 million from the government to speed up the manufacturing of drugs being tested and used to fight the new coronavirus.

The company said it would also use the grant to advance the production of medicines at risk of shortage. (prn.to/36eitka)

(This story corrects typo in second paragraph, adds dropped word in headline)

Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Saumyadeb Chakrabarty

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below